– Improve financial outcomes by taking control of your rebates – Driving growth and trust in the supply chain industry By Brent MacDonald – Partner at Rising Tide Rebates have become an increasingly popular way for distributors to boost their profits. However, the logistical and technical side of issuing rebates, including the tracking and validation of terms, […]

– Transforming AI infrastructure by accelerating data movement – Solving Data Bottlenecks with Optical I/O By Brent MacDonald – Partner at Rising Tide As the complexity and size of AI models increase, traditional interconnect technology creates data bottlenecks that force GPUs and other accelerators to sit idle, limiting compute performance, increasing power consumption, and driving up costs. […]

– Artificial intelligence-powered auctions to optimize financial trading By Brent MacDonald – Partner at Rising Tide In the U.S. alone, over $250 billion of equities trade every day (WSJ). OneChronos is building a financial exchange that dramatically reduces the costs and complexities of trading. Additionally, the Company’s novel auction-matching system is disrupting the archaic continuous limit-order book […]

– Delivering a premium solution to restore the full range of functional vision, with minimal visual disturbances, for cataract patients By Brent MacDonald – Partner at Rising Tide According to the World Health Organization, nearly 94 million people worldwide are visually impaired due to cataracts, which can lead to blindness if untreated. Even though distance correction […]

– AI-enhanced platform creates entirely new drugs by engineering synthetic molecules to mimic nature’s macrocycles By Brent MacDonald – Partner at Rising Tide Established technologies only address a fraction of the drug targets that could make an impact on human health. Unnatural Products (UNP) has developed a machine learning platform to iteratively optimize macrocycle design and predict […]

– Removing the barriers historically associated with protein therapeutics By Brent MacDonald – Partner at Rising Tide The current biologics market suffers from high production costs, shortfalls, and deficient performance in product half-life. Therapeutic proteins are often made in expensive systems because they have chemical bonds that do not form in microbes. GRO Biosciences, also known as […]